Genetic defects in the human glycome
暂无分享,去创建一个
[1] D. Gilbert,et al. An updated review of the long-term neurological effects of galactosemia. , 2005, Pediatric neurology.
[2] Munhyang Lee,et al. Worldwide distribution and broader clinical spectrum of muscle-eye-brain disease. , 2003, Human molecular genetics.
[3] J. Hancock. GPI-anchor synthesis: Ras takes charge. , 2004, Developmental cell.
[4] R. Wevers,et al. Clinical and biochemical presentation of siblings with COG-7 deficiency, a lethal multiple O- and N-glycosylation disorder , 2005, Journal of Inherited Metabolic Disease.
[5] Rita Gerardy-Schahn,et al. The gene defective in leukocyte adhesion deficiency II encodes a putative GDP-fucose transporter , 2001, Nature Genetics.
[6] A Etzioni,et al. Brief report: recurrent severe infections caused by a novel leukocyte adhesion deficiency. , 1992, The New England journal of medicine.
[7] B. Hagberg,et al. Carbohydrate-deficient glycoprotein syndromes: peculiar group of new disorders. , 1993, Pediatric neurology.
[8] Ron A Wevers,et al. Mechanisms in protein O-glycan biosynthesis and clinical and molecular aspects of protein O-glycan biosynthesis defects: a review. , 2006, Clinical chemistry.
[9] Amos Etzioni,et al. Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency , 2001, Nature Genetics.
[10] Carolyn R. Bertozzi,et al. Essentials of Glycobiology , 1999 .
[11] M. Krieger,et al. Retrograde transport on the COG railway. , 2006, Trends in cell biology.
[12] K. Petry,et al. Altered Follicle Stimulating Hormone Isoforms in Female Galactosaemia Patients , 1997, European Journal of Pediatrics.
[13] H. Freeze,et al. Correction of leukocyte adhesion deficiency type II with oral fucose. , 1999, Blood.
[14] A. Helenius,et al. Carbohydrate-deficient glycoprotein syndromes become congenital disorders of glycosylation: An updated nomenclature for CDG , 1999, Glycoconjugate Journal.
[15] D. Kelleher,et al. An evolving view of the eukaryotic oligosaccharyltransferase. , 2006, Glycobiology.
[16] R. Proia,et al. Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[17] J. Denecke,et al. Congenital disorders of glycosylation: review of their molecular bases, clinical presentations and specific therapies , 2003, European Journal of Pediatrics.
[18] M. Huynen,et al. POMT2 mutations cause α-dystroglycan hypoglycosylation and Walker-Warburg syndrome , 2005, Journal of Medical Genetics.
[19] A. Shestakova,et al. COG Complex‐Mediated Recycling of Golgi Glycosyltransferases is Essential for Normal Protein Glycosylation , 2006, Traffic.
[20] R. Campbell,et al. Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis. , 2001, Glycobiology.
[21] K. Campbell,et al. Molecular Recognition by LARGE Is Essential for Expression of Functional Dystroglycan , 2004, Cell.
[22] K. Hoyte,et al. Overexpression of the cytotoxic T cell GalNAc transferase in skeletal muscle inhibits muscular dystrophy in mdx mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[23] L. Elsas,et al. GALT deficiency causes UDP-hexose deficit in human galactosemic cells. , 2003, Glycobiology.
[24] H. Freeze,et al. Cryptogenic Liver Disease in Four Children: A Novel Congenital Disorder of Glycosylation , 2006, Pediatric Research.
[25] R. Wevers,et al. Patients with unsolved congenital disorders of glycosylation type II can be subdivided in six distinct biochemical groups. , 2005, Glycobiology.
[26] D. Dykxhoorn,et al. Genetic Analysis of the Subunit Organization and Function of the Conserved Oligomeric Golgi (COG) Complex , 2005, Journal of Biological Chemistry.
[27] G. Matthijs,et al. Carbohydrate deficient glycoprotein (CDG) syndrome type I. , 1997, Journal of medical genetics.
[28] G. Matthijs,et al. Phosphomannomutase deficiency: the molecular basis of the classical Jaeken syndrome (CDGS type Ia). , 1999, Molecular genetics and metabolism.
[29] M. Schwartz,et al. Carbohydrate-deficient glycoprotein syndrome type 1A: expression and characterisation of wild type and mutant PMM2 in E. coli , 1999, European Journal of Human Genetics.
[30] G. Matthijs,et al. Effect of mutations found in carbohydrate‐deficient glycoprotein syndrome type IA on the activity of phosphomannomutase 2 , 1999, FEBS letters.
[31] J. Dennis,et al. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation , 2001, Nature.
[32] H. Freeze. Update and perspectives on congenital disorders of glycosylation. , 2001, Glycobiology.
[33] R. U. Margolis,et al. Demonstration of mammalian protein O-mannosyltransferase activity: coexpression of POMT1 and POMT2 required for enzymatic activity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[34] M. Schwartz,et al. Lack of Hardy-Weinberg equilibrium for the most prevalent PMM2 mutation in CDG-Ia (congenital disorders of glycosylation type Ia) , 2000, European Journal of Human Genetics.
[35] S. Kornfeld,et al. Assembly of asparagine-linked oligosaccharides. , 1985, Annual review of biochemistry.
[36] W. Canfield,et al. Mucolipidosis II (I-cell disease) and mucolipidosis IIIA (classical pseudo-hurler polydystrophy) are caused by mutations in the GlcNAc-phosphotransferase alpha / beta -subunits precursor gene. , 2006, American journal of human genetics.
[37] Larry J. Smith. Paroxysmal Nocturnal Hemoglobinuria , 2004, American Society for Clinical Laboratory Science.
[38] H. Brunner,et al. Glyc‐O‐genetics of Walker–Warburg syndrome , 2004, Clinical genetics.
[39] K. Campbell,et al. LARGE can functionally bypass α-dystroglycan glycosylation defects in distinct congenital muscular dystrophies , 2004, Nature Medicine.
[40] J. Lowe,et al. Fucose: biosynthesis and biological function in mammals. , 2003, Glycobiology.
[41] F. Muntoni. Journey into muscular dystrophies caused by abnormal glycosylation. , 2004, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.
[42] Susan C. Brown,et al. Defective glycosylation in congenital muscular dystrophies , 2004, Current opinion in neurology.
[43] P. Dawson,et al. Pathogenetics of the human SLC26 transporters. , 2005, Current medicinal chemistry.
[44] M. Betenbaugh,et al. Controlling N-linked glycan site occupancy. , 2005, Biochimica et biophysica acta.
[45] Wenli Zhang,et al. The role of defective glycosylation in congenital muscular dystrophy , 2003, Glycoconjugate Journal.
[46] W. Young. Organization of Golgi Glycosyltransferases in Membranes: Complexity via Complexes , 2004, The Journal of Membrane Biology.
[47] W. Lennarz,et al. The molecular basis of coupling of translocation and N-glycosylation. , 2006, Trends in biochemical sciences.
[48] R. Dwek,et al. Infantile-onset symptomatic epilepsy syndrome caused by a homozygous loss-of-function mutation of GM3 synthase , 2004, Nature Genetics.
[49] J. Mcgill,et al. Congenital disorder of glycosylation type Ia in a 6-year-old girl with a mild intellectual phenotype: Two novel PMM2 mutations , 2005, Journal of Inherited Metabolic Disease.
[50] R. U. Margolis,et al. High prevalence of 2-mono- and 2,6-di-substituted manol-terminating sequences among O-glycans released from brain glycopeptides by reductive alkaline hydrolysis. , 1999, European journal of biochemistry.
[51] G. Matthijs,et al. Annals of the New York Academy of Sciences Congenital Disorders of Glycosylation , 2022 .
[52] H. Freeze,et al. Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. , 1998, The Journal of clinical investigation.
[53] K. Hwa. Glycosyl phosphatidylinositol-linked glycoconjugates: structure, biosynthesis and function. , 2001, Advances in experimental medicine and biology.
[54] N. Callewaert,et al. Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[55] D. Behar,et al. Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis , 2004, Nature Genetics.
[56] Gerhard K. H. Przemeck,et al. Targeted disruption of the Walker-Warburg syndrome gene Pomt1 in mouse results in embryonic lethality. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[57] Guillaume Vogt,et al. Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations , 2005, Nature Genetics.
[58] J. Dennis,et al. N-Acetylglucosaminyltransferase V (Mgat5)-Mediated N-Glycosylation Negatively Regulates Th1 Cytokine Production by T Cells1 , 2004, The Journal of Immunology.
[59] Z. Werb,et al. Mice deficient in Ext2 lack heparan sulfate and develop exostoses , 2005, Development.
[60] J. Marth,et al. Alpha-Mannosidase-II Deficiency Results in Dyserythropoiesis and Unveils an Alternate Pathway in Oligosaccharide Biosynthesis , 1997, Cell.
[61] R. Spiro. Protein glycosylation: nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds. , 2002, Glycobiology.
[62] E. Mercuri,et al. Spectrum of brain changes in patients with congenital muscular dystrophy and FKRP gene mutations. , 2006, Archives of neurology.
[63] V. Lemmon,et al. A genetic model for muscle–eye–brain disease in mice lacking protein O-mannose 1,2-N-acetylglucosaminyltransferase (POMGnT1) , 2006, Mechanisms of Development.
[64] M. Mizuno,et al. Muscular dystrophy and neuronal migration disorder caused by mutations in a glycosyltransferase, POMGnT1. , 2001, Developmental cell.
[65] F. Muntoni,et al. The congenital muscular dystrophies in 2004: a century of exciting progress , 2004, Neuromuscular Disorders.
[66] R. Oriol,et al. Genetic complementation reveals a novel human congenital disorder of glycosylation of type II, due to inactivation of the Golgi CMP-sialic acid transporter. , 2005, Blood.
[67] M. Götte,et al. Defective Glycosaminoglycan Substitution of Decorin in a Patient With Progeroid Syndrome Is a Direct Consequence of Two Point Mutations in the Galactosyltransferase I (ß4galT-7) Gene , 2005, Biochemical Genetics.
[68] Mitsue Sano,et al. The conserved oligomeric Golgi complex acts in organ morphogenesis via glycosylation of an ADAM protease in C. elegans , 2005, Development.
[69] B. Henrissat,et al. Mucolipidosis II is caused by mutations in GNPTA encoding the α/β GlcNAc-1-phosphotransferase , 2005, Nature Medicine.
[70] K. Venkatachalam. Human 3'‐phosphoadenosine 5'‐phosphosulfate (PAPS) Synthase: Biochemistry, Molecular Biology and Genetic Deficiency , 2003, IUBMB life.
[71] R. Cummings,et al. Protein glycosylation: Chaperone mutation in Tn syndrome , 2005, Nature.
[72] H. Freeze,et al. Functional significance of PMM2 mutations in mildly affected patients with congenital disorders of glycosylation Ia , 2001, Genetics in Medicine.
[73] W. Welch,et al. Role of quality control pathways in human diseases involving protein misfolding. , 2004, Seminars in cell & developmental biology.
[74] E. Schaftingen,et al. Biochemical and molecular studies in 26 Spanish patients with congenital disorder of glycosylation type Ia , 2003, Journal of Inherited Metabolic Disease.
[75] N. Leslie. Insights into the pathogenesis of galactosemia. , 2003, Annual review of nutrition.
[76] M. Matzuk,et al. Disruption of gastrulation and heparan sulfate biosynthesis in EXT1-deficient mice. , 2000, Developmental biology.
[77] R. Proia. Gangliosides help stabilize the brain , 2004, Nature Genetics.
[78] J. Marth,et al. Dietary and Genetic Control of Glucose Transporter 2 Glycosylation Promotes Insulin Secretion in Suppressing Diabetes , 2005, Cell.
[79] S. Fukumoto. Post‐translational Modification of Fibroblast Growth Factor 23 , 2005, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[80] H. Freeze,et al. Leukocyte adhesion deficiency II syndrome, a generalized defect in fucose metabolism☆☆☆ , 1999, The Journal of Pediatrics.
[81] François Stricher,et al. SNPeffect: a database mapping molecular phenotypic effects of human non-synonymous coding SNPs , 2004, Nucleic Acids Res..
[82] S. Kornfeld,et al. COG-7-deficient Human Fibroblasts Exhibit Altered Recycling of Golgi Proteins. , 2006, Molecular biology of the cell.
[83] S. Kornfeld,et al. Mannose 6-phosphate receptors: new twists in the tale , 2003, Nature Reviews Molecular Cell Biology.
[84] R. Senger,et al. Variable Site‐Occupancy Classification of N‐Linked Glycosylation Using Artificial Neural Networks , 2005, Biotechnology progress.
[85] Markus Aebi,et al. Altered glycan structures: the molecular basis of congenital disorders of glycosylation. , 2005, Current opinion in structural biology.
[86] M. Sacher. Membrane traffic fuses with cartilage development , 2003, FEBS letters.
[87] T. Nilsson,et al. Association of the Golgi UDP-galactose transporter with UDP-galactose:ceramide galactosyltransferase allows UDP-galactose import in the endoplasmic reticulum. , 2003, Molecular biology of the cell.
[88] J. Denecke,et al. Congenital Disorder of Glycosylation Type Id: Clinical Phenotype, Molecular Analysis, Prenatal Diagnosis, and Glycosylation of Fetal Proteins , 2005, Pediatric Research.
[89] C. Scriver,et al. The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.
[90] S. Selleck,et al. Order out of chaos: assembly of ligand binding sites in heparan sulfate. , 2002, Annual review of biochemistry.
[91] P. Orlik,et al. An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia. , 2005, Human molecular genetics.
[92] E. Engvall,et al. The new frontier in muscular dystrophy research: booster genes , 2003, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[93] P. Nowell. Phytohemagglutinin: an initiator of mitosis in cultures of normal human leukocytes. , 1960, Cancer research.
[94] J. Esko,et al. Hereditary multiple exostoses and heparan sulfate polymerization. , 2002, Biochimica et biophysica acta.
[95] M. Zaffanello,et al. Hypoglycosylation with increased fucosylation and branching of serum transferrin N-glycans in untreated galactosemia. , 2005, Glycobiology.
[96] M. Raghunath,et al. Truncated profibrillin of a Marfan patient is of apparent similar size as fibrillin: intracellular retention leads to over-N-glycosylation. , 1995, Journal of molecular biology.
[97] H. Freeze,et al. Reduced heparan sulfate accumulation in enterocytes contributes to protein-losing enteropathy in a congenital disorder of glycosylation. , 2000, The American journal of pathology.
[98] J. Paulson,et al. Human Disease Glycomics/Proteome Initiative Workshop and the 4th HUPO Annual Congress , 2006, Proteomics.
[99] H. Mitsuya,et al. Immunoselection by natural killer cells of PIGA mutant cells missing stress-inducible ULBP. , 2006, Blood.
[100] E. Berger,et al. Deficiency of UDP-galactose:N-acetylglucosamine beta-1,4-galactosyltransferase I causes the congenital disorder of glycosylation type IId. , 2002, The Journal of clinical investigation.
[101] L. Peltonen,et al. A point mutation creating an extra N-glycosylation site in fibrillin-1 results in neonatal Marfan syndrome. , 1996, Genomics.
[102] R. Wevers,et al. Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis. , 2003, Clinical chemistry.
[103] S. Hakomori. Carbohydrate-to-carbohydrate interaction, through glycosynapse, as a basis of cell recognition and membrane organization , 2004, Glycoconjugate Journal.
[104] M. Hultén. Chiasma distribution at diakinesis in the normal human male. , 2009, Hereditas.
[105] R. Wevers,et al. Defective protein glycosylation in patients with cutis laxa syndrome , 2005, European Journal of Human Genetics.
[106] J. Paulson,et al. Glycomics: an integrated systems approach to structure-function relationships of glycans , 2005, Nature Methods.
[107] A. Nishikawa,et al. The efficiency of N-linked glycosylation of bovine DNase I depends on the Asn-Xaa-Ser/Thr sequence and the tissue of origin. , 2001, The Biochemical journal.
[108] J. Rowley. A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining , 1973, Nature.
[109] H. Harris,et al. Hybrid Cells Derived from Mouse and Man : Artificial Heterokaryons of Mammalian Cells from Different Species , 1965, Nature.
[110] A. Tárnok,et al. Correction: Protein-losing enteropathy in patients with Fontan circulation: is it triggered by infection? , 2003, Critical care.
[111] N. Debili,et al. Macrothrombocytopenia with abnormal demarcation membranes in megakaryocytes and neutropenia with a complete lack of sialyl-Lewis-X antigen in leukocytes--a new syndrome? , 2001, Blood.
[112] O. Bohorov,et al. Mutation of the COG complex subunit gene COG7 causes a lethal congenital disorder , 2004, Nature Medicine.
[113] E. Schaftingen,et al. High residual activity of PMM2 in patients' fibroblasts: possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency). , 2001, American journal of human genetics.
[114] J. Jaeken,et al. Congenital disorders of glycosylation (CDG): It's all in it! , 2003, Journal of Inherited Metabolic Disease.
[115] P. Kwok,et al. Identification of a frequent variant in ALG6, the cause of Congenital Disorder of Glycosylation‐Ic , 2003, Human mutation.
[116] P. de Cock,et al. Carbohydrate deficient glycoprotein syndrome type II: a deficiency in Golgi localised N-acetyl-glucosaminyltransferase II. , 1994, Archives of disease in childhood.
[117] Lawrence A Tabak,et al. All in the family: the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases. , 2003, Glycobiology.
[118] H. Freeze,et al. Applied glycoproteomics--approaches to study genetic-environmental collisions causing protein-losing enteropathy. , 2006, Biochimica et biophysica acta.
[119] J. Jaeken,et al. Congenital disorders of glycosylation: a booming chapter of pediatrics. , 2004, Current opinion in pediatrics.
[120] M. Fukuda. HEMPAS. Hereditary erythroblastic multinuclearity with positive acidified serum lysis test. , 1999, Biochimica et Biophysica Acta.
[121] H. Freeze,et al. Glycobiology of neuromuscular disorders. , 2003, Glycobiology.
[122] J. Jaeken,et al. Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development. , 1996, American journal of human genetics.